I

n awarding the Nobel Prize in chemistry to scientists who had developed a new way of seeing the structure of biomolecules, the Nobel committee this week noted that the technology is more than a tool for basic research. It’s also “decisive…for the development of pharmaceuticals,” the committee said.

Biopharma companies absolutely agree.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.

X